US 12331127
Therapeutic uses of anti-GITR antibodies
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 12331127 (Therapeutic uses of anti-GITR antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 55
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/3955, A61P